Janis, Jeffrey E <br/><br/>
Does empiric antibiotic therapy change MRSA [corrected] hand infection outcomes? Cost analysis of a randomized prospective trial in a county hospital.  [electronic resource] 

 -  Plastic and reconstructive surgery  Apr 2014 
 - 511e-518e p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1529-4242 
<br/><br/><label>Standard No.: </label>10.1097/PRS.0000000000000018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abscess--drug therapy<br/>Adult<br/>Anti-Bacterial Agents--administration & dosage<br/>Cefazolin--administration & dosage<br/>Community-Acquired Infections<br/>Cost-Benefit Analysis<br/>Costs and Cost Analysis<br/>Female<br/>Hand--microbiology<br/>Hospital Costs<br/>Hospitals, County<br/>Humans<br/>Length of Stay<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Severity of Illness Index<br/>Soft Tissue Infections--drug therapy<br/>Staphylococcal Infections--drug therapy<br/>Vancomycin--administration & dosage